Last reviewed · How we verify
V-SARS
At a glance
| Generic name | V-SARS |
|---|---|
| Sponsor | Immunitor LLC |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses (NA)
- COVID-19 Related Lung Ventilation and Perfusion Injury
- Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-0669 in Healthy Adult Participants (PHASE1)
- A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults (PHASE1)
- Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines (PHASE1, PHASE2)
- The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients (PHASE2, PHASE3)
- Trial of Treatments for COVID-19 in Hospitalized Adults (PHASE3)
- Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- V-SARS CI brief — competitive landscape report
- V-SARS updates RSS · CI watch RSS
- Immunitor LLC portfolio CI